Fig. 1 · Structure
Documents & Downloads
Latanoprost acid
FP Agonist
Latanoprost acid is a selective FP prostanoid receptor agonist that primarily targets the FP receptor. It exhibits significant biological activity by inhibiting RANKL-induced osteoclastogenesis and functionality through the modulation of the ERK, AKT, JNK, and p38 signaling pathways, subsequently affecting the c-fos/NFATc1 pathway. Additionally, Latanoprost acid is utilized for therapeutic applications aimed at reducing intraocular pressure in conditions such as glaucoma.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Agonist |
| CAS Number | 41639-83-2 |
| Applications | FP Agonist |
| Formula | C23H34O5 |
| Molecular Weight | 390.51 |
| SMILES | O[C@@H]1[C@@H]([C@H]([C@@H](C1)O)CC[C@H](CCC2=CC=CC=C2)O)C/C=C\CCCC(O)=O |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.